Moderna Inc (MRNA)

Moderna Inc (MRNA) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $79.9B; returns 1 day -1.2%, 1 week -8.2%, 1 year +662.3%.

Moderna Inc. is a leading biotechnology company primarily focused on developing messenger RNA (mRNA) therapeutics and vaccines. As of January 2026, the company's revenue is predominantly driven by its commercialized COVID-19 vaccines (Spikevax and mNEXSPIKE) and its recently launched Respiratory Syncytial Virus (RSV) vaccine, mRESVIA.

Groups MRNA belongs to

• Biotechnology
• S&P 500
• Healthcare
• Pharmaceuticals
• Life Sciences
• Biopharmaceutical
• COVID-19
• Commercial Stage
• Commercial Stage Biotech
• Infectious Diseases
• Oncology

MRNA financial model: income statement, cash flow and balance sheet